Pfizer (PFE) Reports Top-Line Results of ABRYSVO for RSV in Immunocompromised Adults
Go back to Pfizer (PFE) Reports Top-Line Results of ABRYSVO for RSV in Immunocompromised Adults| Pfizer Inc. (NYSE: PFE) | Delayed: 27.79 -0.66 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.45 | 52 Week High | $37.39 | |||
| Open | $28.01 | 52 Week Low | $28.25 | |||
| Day High | $28.15 | P/E | 16.84 | |||
| Day Low | $27.72 | EPS | $1.65 | |||
| Volume | 31,752,270 | |||||
